SIMILAR PATTERNS OF AMINO ACIDS FOR 1A4G_A_ZMRA466
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ct9 | ASPARAGINESYNTHETASE B (Escherichiacoli) |
PF00733(Asn_synthase)PF13537(GATase_7) | 5 | ARG A 309ARG A 498GLU A 499ALA A 511GLU A 502 | None | 1.42A | 1a4gA-1ct9A:undetectable | 1a4gA-1ct9A:19.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ms8 | TRANS-SIALIDASE (Trypanosomacruzi) |
PF13385(Laminin_G_3)PF13859(BNR_3) | 6 | ARG A 35ASP A 59GLU A 230ARG A 245ARG A 314TYR A 342 | DAN A 700 (-3.0A)DAN A 700 (-2.7A)DAN A 700 (-3.3A)DAN A 700 (-2.8A)DAN A 700 (-3.0A)DAN A 700 (-3.5A) | 0.87A | 1a4gA-1ms8A:23.8 | 1a4gA-1ms8A:19.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mz5 | SIALIDASE (Trypanosomarangeli) |
PF13385(Laminin_G_3)PF13859(BNR_3) | 6 | ARG A 36ASP A 60GLU A 231ARG A 246ARG A 315TYR A 343 | None | 0.60A | 1a4gA-1mz5A:24.1 | 1a4gA-1mz5A:20.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG N 118GLU N 119ARG N 224GLU N 227ALA N 246GLU N 276GLU N 277ARG N 292ASN N 294TYR N 406 | None | 0.73A | 1a4gA-1nmbN:53.6 | 1a4gA-1nmbN:28.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG N 118GLU N 119ARG N 224GLU N 227ALA N 246GLU N 277ARG N 292ASN N 294ARG N 371TYR N 406 | None | 0.63A | 1a4gA-1nmbN:53.6 | 1a4gA-1nmbN:28.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG N 118GLU N 119ASP N 151ARG N 224GLU N 227GLU N 276GLU N 277ARG N 292ASN N 294TYR N 406 | None | 0.83A | 1a4gA-1nmbN:53.6 | 1a4gA-1nmbN:28.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG N 118GLU N 119ASP N 151ARG N 224GLU N 227GLU N 277ARG N 292ASN N 294ARG N 371TYR N 406 | None | 0.75A | 1a4gA-1nmbN:53.6 | 1a4gA-1nmbN:28.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG N 118GLU N 119ASP N 151ASN N 347TYR N 406 | None | 1.20A | 1a4gA-1nmbN:53.6 | 1a4gA-1nmbN:28.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU N 227ALA N 246ARG N 292ASN N 294TYR N 406 | None | 1.25A | 1a4gA-1nmbN:53.6 | 1a4gA-1nmbN:28.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v0z | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 124GLU A 125ASP A 157ARG A 231GLU A 234ALA A 253GLU A 283GLU A 284ARG A 299ASN A 301ARG A 378TYR A 412 | None | 0.58A | 1a4gA-1v0zA:53.8 | 1a4gA-1v0zA:32.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 11 | ARG A 116GLU A 117ASP A 149ARG A 223GLU A 226ALA A 245GLU A 276ARG A 292ASN A 294ARG A 374TYR A 409 | IBA A 1 (-3.3A)IBA A 1 (-3.9A)IBA A 1 (-3.6A)IBA A 1 ( 4.5A)IBA A 1 (-3.9A)IBA A 1 ( 3.9A)IBA A 1 (-3.9A)IBA A 1 (-3.5A)IBA A 1 ( 3.9A)IBA A 1 (-3.2A)None | 0.49A | 1a4gA-1vcjA:73.9 | 1a4gA-1vcjA:94.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 7 | ARG A 116GLU A 117ASP A 149ARG A 223GLU A 275GLU A 276TYR A 409 | IBA A 1 (-3.3A)IBA A 1 (-3.9A)IBA A 1 (-3.6A)IBA A 1 ( 4.5A)IBA A 1 (-4.1A)IBA A 1 (-3.9A)None | 1.22A | 1a4gA-1vcjA:73.9 | 1a4gA-1vcjA:94.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 5 | GLU A 226ALA A 245ARG A 292ASN A 294TYR A 409 | IBA A 1 (-3.9A)IBA A 1 ( 3.9A)IBA A 1 (-3.5A)IBA A 1 ( 3.9A)None | 1.18A | 1a4gA-1vcjA:73.9 | 1a4gA-1vcjA:94.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w8o | BACTERIAL SIALIDASE (Micromonosporaviridifaciens) |
PF00754(F5_F8_type_C)PF10633(NPCBM_assoc)PF13088(BNR_2) | 5 | ARG A 68GLU A 260ARG A 276ARG A 342TYR A 370 | CIT A1649 ( 2.6A)GOL A1651 (-3.6A)CIT A1649 ( 2.7A)CIT A1649 ( 2.9A)CIT A1649 (-4.5A) | 0.32A | 1a4gA-1w8oA:25.8 | 1a4gA-1w8oA:20.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.61A | 1a4gA-1xogA:53.4 | 1a4gA-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.99A | 1a4gA-1xogA:53.4 | 1a4gA-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 226GLU A 229ALA A 248GLU A 278ASN A 296 | NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 ( 4.0A) | 0.98A | 1a4gA-1xogA:53.4 | 1a4gA-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU A 120ALA A 248ARG A 294ASN A 296TYR A 406 | ABW A1000 (-3.7A)ABW A1000 ( 3.8A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-4.9A) | 1.24A | 1a4gA-1xogA:53.4 | 1a4gA-1xogA:30.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) |
PF13088(BNR_2) | 6 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.47A | 1a4gA-2bf6A:25.0 | 1a4gA-2bf6A:22.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2f28 | SIALIDASE 2 (Homo sapiens) |
PF13088(BNR_2) | 5 | ARG A 21GLU A 218ARG A 237ARG A 304TYR A 334 | None | 0.42A | 1a4gA-2f28A:25.2 | 1a4gA-2f28A:21.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fpg | SUCCINYL-COA LIGASE[GDP-FORMING]ALPHA-CHAIN,MITOCHONDRIALSUCCINYL-COA LIGASE[GDP-FORMING]BETA-CHAIN,MITOCHONDRIAL (Sus scrofa) |
PF00549(Ligase_CoA)PF02629(CoA_binding)PF08442(ATP-grasp_2) | 5 | GLU A 224ALA A 247GLU A 223ARG A 161ARG B 123 | None | 1.48A | 1a4gA-2fpgA:undetectable | 1a4gA-2fpgA:20.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gfg | BH2851 (Bacillushalodurans) |
PF01928(CYTH) | 5 | ARG A 184GLU A 149GLU A 151GLU A 6GLU A 8 | EDO A 503 (-4.2A)EDO A 503 (-3.0A)UNL A 500 ( 2.8A)UNL A 500 ( 3.9A)EDO A 503 ( 3.9A) | 1.42A | 1a4gA-2gfgA:undetectable | 1a4gA-2gfgA:19.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 9 | ARG A 118ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | None | 0.61A | 1a4gA-2htvA:51.8 | 1a4gA-2htvA:36.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | ARG A 118ASP A 151ARG A 224GLU A 227GLU A 277ARG A 371TYR A 406 | None | 0.67A | 1a4gA-2htvA:51.8 | 1a4gA-2htvA:36.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | GLU A 119ARG A 224GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | None | 1.06A | 1a4gA-2htvA:51.8 | 1a4gA-2htvA:36.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vdw | VACCINIA VIRUSCAPPING ENZYME D1SUBUNIT (Vaccinia virus) |
PF03291(Pox_MCEL) | 5 | ARG A 655ASP A 598GLU A 652ALA A 625ARG A 548 | SAH A1846 (-3.4A)SAH A1846 (-3.1A)NoneSAH A1846 ( 4.9A)SAH A1846 (-3.2A) | 1.48A | 1a4gA-2vdwA:undetectable | 1a4gA-2vdwA:22.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w20 | SIALIDASE A (Streptococcuspneumoniae) |
PF13088(BNR_2) | 6 | ARG A 347ASP A 372GLU A 647ARG A 663ARG A 721TYR A 752 | None | 0.58A | 1a4gA-2w20A:25.1 | 1a4gA-2w20A:21.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xzi | EXTRACELLULARSIALIDASE/NEURAMINIDASE, PUTATIVE (Aspergillusfumigatus) |
PF13088(BNR_2) | 6 | ARG A 59ASP A 84GLU A 249ARG A 265ARG A 322TYR A 358 | KDM A 500 (-2.7A)KDM A 500 (-2.8A)KDM A 500 (-3.6A)KDM A 500 (-2.7A)KDM A 500 ( 3.0A)KDM A 500 (-4.5A) | 0.38A | 1a4gA-2xziA:12.5 | 1a4gA-2xziA:22.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.39A | 1a4gA-3ckzA:53.6 | 1a4gA-3ckzA:34.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3juu | PORPHYRANASE B (Zobelliagalactanivorans) |
PF00722(Glyco_hydro_16) | 5 | ARG A 70GLU A 256GLU A 161ASN A 183TYR A 258 | GOL A 294 (-3.3A)GOL A 294 (-2.7A)GOL A 294 (-3.1A)NoneNone | 1.45A | 1a4gA-3juuA:undetectable | 1a4gA-3juuA:22.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pfo | PUTATIVEACETYLORNITHINEDEACETYLASE (Rhodopseudomonaspalustris) |
PF01546(Peptidase_M20)PF07687(M20_dimer) | 5 | ARG A 41GLU A 178GLU A 176ASN A 182ARG A 380 | None ZN A 451 (-2.0A)NoneNoneNone | 1.42A | 1a4gA-3pfoA:undetectable | 1a4gA-3pfoA:23.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qfi | TRANSCRIPTIONALREGULATOR (Enterococcusfaecalis) |
PF03816(LytR_cpsA_psr) | 5 | ARG A 197ASP A 70ARG A 104ASN A 120ARG A 209 | None | 1.50A | 1a4gA-3qfiA:undetectable | 1a4gA-3qfiA:22.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sil | SIALIDASE (Salmonellaenterica) |
PF13859(BNR_3) | 6 | ARG A 37ASP A 62GLU A 231ARG A 246ARG A 309TYR A 342 | PO4 A 499 (-2.7A)GOL A 403 ( 3.4A)GOL A 402 (-3.3A)PO4 A 499 (-2.7A)PO4 A 499 (-3.0A)PO4 A 499 (-4.6A) | 0.74A | 1a4gA-3silA:23.5 | 1a4gA-3silA:21.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ti8 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | LNV A 901 (-3.0A)LNV A 901 (-3.6A)LNV A 901 (-3.4A)LNV A 901 (-4.1A)LNV A 901 (-3.4A)LNV A 901 (-3.5A)LNV A 901 (-2.9A)LNV A 901 ( 3.8A)LNV A 901 (-2.8A)LNV A 901 (-4.0A)LNV A 901 (-2.9A)LNV A 901 (-4.8A) | 0.38A | 1a4gA-3ti8A:53.9 | 1a4gA-3ti8A:36.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tia | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | LNV A 801 (-2.8A)LNV A 801 (-3.5A)LNV A 801 (-3.4A)LNV A 801 (-4.2A)LNV A 801 (-3.5A)LNV A 801 (-3.4A)LNV A 801 (-2.9A)LNV A 801 (-3.8A)LNV A 801 (-3.0A)LNV A 801 (-4.0A)LNV A 801 (-2.9A)LNV A 801 (-4.4A) | 0.43A | 1a4gA-3tiaA:55.2 | 1a4gA-3tiaA:28.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zie | SEPF-LIKE PROTEIN (Archaeoglobusfulgidus) |
PF04472(SepF) | 5 | ARG A 55GLU A 52GLU A 56ARG A 40TYR A 38 | None | 1.15A | 1a4gA-3zieA:undetectable | 1a4gA-3zieA:14.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b7j | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 9 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ASN A 295TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 ( 3.7A)G39 A1470 (-4.5A) | 0.68A | 1a4gA-4b7jA:53.0 | 1a4gA-4b7jA:31.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b7j | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.46A | 1a4gA-4b7jA:53.0 | 1a4gA-4b7jA:31.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bbw | SIALIDASE(NEURAMINIDASE) (Bacteroidesthetaiotaomicron) |
PF13088(BNR_2)PF14873(BNR_assoc_N) | 5 | ARG A 204ASP A 229GLU A 399ARG A 415TYR A 510 | None | 0.81A | 1a4gA-4bbwA:25.0 | 1a4gA-4bbwA:22.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bbw | SIALIDASE(NEURAMINIDASE) (Bacteroidesthetaiotaomicron) |
PF13088(BNR_2)PF14873(BNR_assoc_N) | 5 | ARG A 204GLU A 399ARG A 415ARG A 479TYR A 510 | None | 0.58A | 1a4gA-4bbwA:25.0 | 1a4gA-4bbwA:22.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ckb | MRNA-CAPPING ENZYMECATALYTIC SUBUNIT (Vaccinia virus) |
PF03291(Pox_MCEL)PF10640(Pox_ATPase-GT) | 5 | ARG A 655ASP A 598GLU A 652ALA A 625ARG A 548 | SAH A1845 (-3.3A)SAH A1845 (-3.5A)NoneSAH A1845 ( 4.7A)SAH A1845 (-3.4A) | 1.40A | 1a4gA-4ckbA:undetectable | 1a4gA-4ckbA:19.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4cpn | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.29A | 1a4gA-4cpnA:75.0 | 1a4gA-4cpnA:94.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fj6 | GLYCOSIDE HYDROLASEFAMILY 33, CANDIDATESIALIDASE (Parabacteroidesdistasonis) |
PF13859(BNR_3)PF14873(BNR_assoc_N) | 6 | ARG A 200ASP A 225GLU A 395ARG A 411ARG A 475TYR A 506 | PO4 A 607 ( 2.6A)PO4 A 607 ( 3.8A)PO4 A 607 ( 4.8A)PO4 A 607 (-2.7A)PO4 A 607 (-2.8A)PO4 A 607 (-4.6A) | 0.49A | 1a4gA-4fj6A:25.0 | 1a4gA-4fj6A:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fzh | HEMAGGLUTININ-NEURAMINIDASE (Avianavulavirus 1) |
PF00423(HN) | 5 | ARG A 174GLU A 401ARG A 416ARG A 498TYR A 526 | None | 0.71A | 1a4gA-4fzhA:23.2 | 1a4gA-4fzhA:20.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4h53 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371 | SLB A 512 (-2.7A)SLB A 512 (-3.5A)SLB A 512 (-3.5A)SLB A 512 (-4.2A)NoneSLB A 512 (-3.3A)SLB A 512 (-2.8A)SLB A 512 (-2.7A)SLB A 512 (-3.1A)SLB A 512 ( 4.2A)SLB A 512 (-2.9A) | 0.47A | 1a4gA-4h53A:55.1 | 1a4gA-4h53A:31.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4h53 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | SLB A 512 (-2.9A)SLB A 512 (-4.2A)SLB A 512 (-3.3A)SLB A 512 (-2.8A)SLB A 512 (-2.7A) | 1.29A | 1a4gA-4h53A:55.1 | 1a4gA-4h53A:31.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hgk | SHARK V-NAR ANTIBODY (Squalusacanthias) |
PF07686(V-set) | 5 | ARG C 73GLU C 66ARG C 57ASN C 59TYR C 74 | None | 1.39A | 1a4gA-4hgkC:undetectable | 1a4gA-4hgkC:15.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 9 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.65A | 1a4gA-4hzzA:52.3 | 1a4gA-4hzzA:33.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.47A | 1a4gA-4hzzA:52.3 | 1a4gA-4hzzA:33.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 1.06A | 1a4gA-4hzzA:52.3 | 1a4gA-4hzzA:33.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jf7 | HEMAGGLUTININ-NEURAMINIDASE (Mammalianrubulavirus 5) |
no annotation | 6 | ARG D 163GLU D 390ARG D 405ASN D 407ARG D 495TYR D 523 | SO4 D 608 ( 4.1A)NoneSO4 D 608 (-2.6A)NoneSO4 D 608 (-3.3A)None | 0.87A | 1a4gA-4jf7D:22.4 | 1a4gA-4jf7D:21.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 8 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.73A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 9 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.51A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 118ASP A 151ARG A 224GLU A 227GLU A 277 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 (-3.4A) | 0.79A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.17A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | GLU A 119ARG A 224ALA A 246GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.05A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU A 227ALA A 246ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.22A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n5f | PUTATIVE ACYL-COADEHYDROGENASE (Burkholderiacenocepacia) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M)PF02771(Acyl-CoA_dh_N) | 5 | ARG A 17GLU A 75ALA A 289ARG A 296ASN A 293 | None | 1.44A | 1a4gA-4n5fA:undetectable | 1a4gA-4n5fA:20.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q6k | BNR/ASP-BOX REPEATPROTEIN (Bacteroidescaccae) |
PF13088(BNR_2)PF14873(BNR_assoc_N) | 6 | ARG A 220ASP A 245GLU A 415ARG A 431ARG A 495TYR A 526 | EDO A 604 (-4.0A)EDO A 604 ( 4.3A)NoneNoneNoneNone | 0.42A | 1a4gA-4q6kA:24.9 | 1a4gA-4q6kA:22.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4qn3 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 36GLU A 37ASP A 69ARG A 143GLU A 146ALA A 165GLU A 195GLU A 196ARG A 211ASN A 213ARG A 290TYR A 324 | None | 0.64A | 1a4gA-4qn3A:53.6 | 1a4gA-4qn3A:33.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4sli | INTRAMOLECULARTRANS-SIALIDASE (Macrobdelladecora) |
PF02973(Sialidase)PF13088(BNR_2) | 5 | ALA A 592GLU A 595ARG A 611ARG A 673TYR A 713 | NoneCNP A 760 ( 4.5A)CNP A 760 (-3.0A)CNP A 760 (-3.0A)CNP A 760 (-4.0A) | 1.06A | 1a4gA-4sliA:24.8 | 1a4gA-4sliA:22.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4sli | INTRAMOLECULARTRANS-SIALIDASE (Macrobdelladecora) |
PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 293ASP A 318GLU A 595ARG A 611ARG A 673TYR A 713 | CNP A 760 (-3.0A)CNP A 760 (-2.6A)CNP A 760 ( 4.5A)CNP A 760 (-3.0A)CNP A 760 (-3.0A)CNP A 760 (-4.0A) | 0.58A | 1a4gA-4sliA:24.8 | 1a4gA-4sliA:22.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4txk | PROTEIN-METHIONINESULFOXIDE OXIDASEMICAL1 (Mus musculus) |
PF00307(CH)PF01494(FAD_binding_3) | 5 | ARG A 230GLU A 373ALA A 473GLU A 437ARG A 371 | None | 1.21A | 1a4gA-4txkA:undetectable | 1a4gA-4txkA:22.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x6k | ANHYDROSIALIDASE ([Ruminococcus]gnavus) |
PF13088(BNR_2) | 5 | ALA A 556GLU A 559ARG A 575ARG A 637TYR A 677 | None3XR A 802 ( 4.7A)3XR A 802 (-2.6A)3XR A 802 (-3.0A)3XR A 802 (-4.2A) | 1.01A | 1a4gA-4x6kA:21.1 | 1a4gA-4x6kA:22.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x6k | ANHYDROSIALIDASE ([Ruminococcus]gnavus) |
PF13088(BNR_2) | 6 | ARG A 257ASP A 282GLU A 559ARG A 575ARG A 637TYR A 677 | 3XR A 802 (-3.0A)3XR A 802 (-2.5A)3XR A 802 ( 4.7A)3XR A 802 (-2.6A)3XR A 802 (-3.0A)3XR A 802 (-4.2A) | 0.58A | 1a4gA-4x6kA:21.1 | 1a4gA-4x6kA:22.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xhb | SIALIDASE B (Streptococcuspneumoniae) |
PF02012(BNR)PF02973(Sialidase)PF13088(BNR_2) | 5 | ALA A 538GLU A 541ARG A 557ARG A 619TYR A 653 | NoneNoneNHE A 702 (-2.8A)NHE A 702 (-2.9A)NHE A 702 (-4.8A) | 1.20A | 1a4gA-4xhbA:22.5 | 1a4gA-4xhbA:19.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xhb | SIALIDASE B (Streptococcuspneumoniae) |
PF02012(BNR)PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 245ASP A 270GLU A 541ARG A 557ARG A 619TYR A 653 | NHE A 702 (-2.7A)NHE A 702 (-3.2A)NoneNHE A 702 (-2.8A)NHE A 702 (-2.9A)NHE A 702 (-4.8A) | 0.59A | 1a4gA-4xhbA:22.5 | 1a4gA-4xhbA:19.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) |
PF02012(BNR)PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.71A | 1a4gA-4yw5A:23.8 | 1a4gA-4yw5A:20.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b2d | HN PROTEIN (Mumpsrubulavirus) |
PF00423(HN) | 5 | ARG A 180GLU A 407ARG A 422ARG A 512TYR A 540 | SLT A 606 (-2.6A)SLT A 606 (-3.8A)SLT A 606 (-3.0A)SLT A 606 (-2.8A)SLT A 606 (-4.7A) | 0.52A | 1a4gA-5b2dA:22.5 | 1a4gA-5b2dA:21.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5czz | CRISPR-ASSOCIATEDENDONUCLEASE CAS9 (Staphylococcusaureus) |
PF13395(HNH_4)PF16592(Cas9_REC) | 5 | ARG A 92GLU A 179ALA A 144ASN A 141TYR A 176 | None | 1.33A | 1a4gA-5czzA:undetectable | 1a4gA-5czzA:16.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dot | CARBAMOYL-PHOSPHATESYNTHASE [AMMONIA],MITOCHONDRIAL (Homo sapiens) |
PF00117(GATase)PF00988(CPSase_sm_chain)PF02142(MGS)PF02786(CPSase_L_D2)PF02787(CPSase_L_D3) | 5 | ARG A 929ASP A 914ARG A 814GLU A1034ARG A1039 | NoneNoneEDO A1603 (-3.9A)EDO A1603 (-2.7A)EDO A1603 ( 3.8A) | 1.30A | 1a4gA-5dotA:undetectable | 1a4gA-5dotA:13.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5iq6 | RNA DEPENDENT RNAPOLYMERASE (Dengue virus) |
PF00972(Flavi_NS5) | 5 | ARG A 438GLU A 486ARG A 391GLU A 397TYR A 482 | None | 1.47A | 1a4gA-5iq6A:undetectable | 1a4gA-5iq6A:19.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u22 | N2152 (Neocallimastixfrontalis) |
PF01229(Glyco_hydro_39) | 5 | ALA A 219GLU A 151GLU A 110ARG A 76ASN A 253 | None | 1.38A | 1a4gA-5u22A:undetectable | 1a4gA-5u22A:22.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5y7i | CHLORIDEINTRACELLULARCHANNEL PROTEIN 2 (Oreochromismossambicus) |
no annotation | 5 | GLU A 88ALA A 180GLU A 87ARG A 35ASN A 183 | None | 1.19A | 1a4gA-5y7iA:undetectable | 1a4gA-5y7iA:9.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6br6 | NEURAMINIDASE (Influenza Avirus) |
no annotation | 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.51A | 1a4gA-6br6A:54.5 | 1a4gA-6br6A:10.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6eks | SIALIDASE (Vibrio cholerae) |
no annotation | 6 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.39A | 1a4gA-6eksA:13.8 | 1a4gA-6eksA:19.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6es9 | ACYL-COADEHYDROGENASE (Paracoccusdenitrificans) |
no annotation | 5 | ARG A 73GLU A 477GLU A 70GLU A 487ARG A 548 | None | 1.36A | 1a4gA-6es9A:undetectable | 1a4gA-6es9A:9.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG N 152ARG N 156TRP N 178ILE N 222 | None | 0.37A | 1a4gA-1nmbN:53.6 | 1a4gA-1nmbN:28.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v0z | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG A 158ARG A 162TRP A 185ILE A 229 | None | 0.19A | 1a4gA-1v0zA:53.8 | 1a4gA-1v0zA:32.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 4 | ARG A 150ARG A 154TRP A 177ILE A 221 | IBA A 1 (-3.9A)IBA A 1 (-4.1A)NoneIBA A 1 ( 4.3A) | 0.41A | 1a4gA-1vcjA:73.9 | 1a4gA-1vcjA:94.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG A 153ARG A 157TRP A 180ILE A 224 | ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.7A) | 0.42A | 1a4gA-1xogA:53.4 | 1a4gA-1xogA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | None | 0.43A | 1a4gA-2htvA:51.8 | 1a4gA-2htvA:36.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.71A | 1a4gA-3ckzA:53.6 | 1a4gA-3ckzA:34.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ti8 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | LNV A 901 (-4.0A)LNV A 901 (-4.0A)NoneNone | 0.12A | 1a4gA-3ti8A:53.9 | 1a4gA-3ti8A:36.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tia | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | LNV A 801 (-3.9A)LNV A 801 (-4.0A)NoneNone | 0.14A | 1a4gA-3tiaA:55.2 | 1a4gA-3tiaA:28.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4cpn | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 4 | ARG A 149ARG A 153TRP A 176ILE A 220 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.12A | 1a4gA-4cpnA:75.0 | 1a4gA-4cpnA:94.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4h53 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | SLB A 512 (-3.8A)NoneNoneNone | 0.15A | 1a4gA-4h53A:55.1 | 1a4gA-4h53A:31.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.16A | 1a4gA-4hzzA:52.3 | 1a4gA-4hzzA:33.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | 27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.64A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4qn3 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 4 | ARG A 70ARG A 74TRP A 97ILE A 141 | None | 0.20A | 1a4gA-4qn3A:53.6 | 1a4gA-4qn3A:33.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6br6 | NEURAMINIDASE (Influenza Avirus) |
no annotation | 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | E3M A 511 (-3.8A)NoneNoneE3M A 511 ( 4.3A) | 0.14A | 1a4gA-6br6A:54.5 | 1a4gA-6br6A:10.51 |